Literature DB >> 19939200

Hepatocyte growth factor--a new marker for prognosis in acute coronary syndrome.

Anna Konopka1, Jadwiga Janas, Walerian Piotrowski, Janina Stepińska.   

Abstract

UNLABELLED: This study was designed to check the properties of hepatocyte growth factor (HGF) as a new marker of myocardial necrosis. MATERIALS AND
METHOD: In one hundred and four patients with acute coronary syndrome (ACS), plasma human HGF (hHGF) concentrations were assessed twice, i.e. just after admission to hospital and 24 h afterwards. The primary composite endpoint was assessed at three-month follow-up.
RESULTS: The maximal concentration of hHGF (1902 pg/ml) was reached at the time of admission to hospital due to ACS with significant decrease 24 h after the first measurement (705 pg/ml p < 0.0001). hHGF levels in ST segment elevation myocardial infarction (STEMI) were higher than in non-ST segment elevation myocardial infarction (NSTEMI) and in patients who reached composite primary endpoint (33 patients-4211 pg/ml) vs. event-free 71 patients (1013 pg/ml p < 0.01). The correlation between values of hHGF and N-terminal prohormone B-type natriuretic peptide and cardiac troponin I was revealed.
CONCLUSION: HGF is a very early, good marker of myocardial necrosis and a sensitive short- and long-term prognostic factor in ACS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19939200     DOI: 10.3109/08977190903403984

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  5 in total

1.  Ad-HGF improves the cardiac remodeling of rat following myocardial infarction by upregulating autophagy and necroptosis and inhibiting apoptosis.

Authors:  Jiabao Liu; Peng Wu; Yunle Wang; Yingqiang Du; Nan A; Shuiyuan Liu; Yiming Zhang; Ningtian Zhou; Zhihui Xu; Zhijian Yang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

Review 2.  Novel therapy for myocardial infarction: can HGF/Met be beneficial?

Authors:  V Sala; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2011-02-17       Impact factor: 9.261

3.  Prognostic tools at hospital arrival in acute myocardial infarction: copeptin and hepatocyte growth factor.

Authors:  María-Consuelo Pintado; Lara Maceda; María Trascasa; Ignacio Arribas; Raúl De Pablo
Journal:  Egypt Heart J       Date:  2022-04-28

4.  Hepatocyte growth factor concentration during the first day of acute coronary syndrome.

Authors:  Anna Konopka; Jadwiga Janas; Janina Stępińska
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

Review 5.  Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review.

Authors:  Mattia Bellan; Luigi Mario Castello; Mario Pirisi
Journal:  J Clin Transl Hepatol       Date:  2018-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.